111 related articles for article (PubMed ID: 14607711)
1. Gene expression of NS5a strong antigenic regions of hepatitis C virus in E.coli and detection of their antigenicity.
Dou XG; Feng GH; Shi LL; Fields H
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):383-7. PubMed ID: 14607711
[TBL] [Abstract][Full Text] [Related]
2. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
[TBL] [Abstract][Full Text] [Related]
3. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
[TBL] [Abstract][Full Text] [Related]
4. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.
Chang JC; Seidel C; Ofenloch B; Jue DL; Fields HA; Khudyakov YE
Virology; 1999 Apr; 257(1):177-90. PubMed ID: 10208931
[TBL] [Abstract][Full Text] [Related]
5. Selection and application of serotypical synthetic peptides derived from hepatitis C virus NS5A region.
Dou XG; Zhang L; Li ZW; Feng GH; Chang J; Fildes H; Khudyakov Y
Chin Med J (Engl); 2007 Jul; 120(13):1159-65. PubMed ID: 17637245
[TBL] [Abstract][Full Text] [Related]
6. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
7. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus.
Claeys H; Volckaerts A; Mertens W; Liang Z; Fiten P; Opdenakker G
J Med Virol; 1995 Mar; 45(3):273-81. PubMed ID: 7539833
[TBL] [Abstract][Full Text] [Related]
8. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity assessment of hepatitis C virus NS3 protease and NS5A proteins expressed in TOPO cloning system.
Alaee M; Rajabi P; Sharifi Z; Farajollahi MM
J Microbiol Immunol Infect; 2014 Aug; 47(4):282-91. PubMed ID: 23040046
[TBL] [Abstract][Full Text] [Related]
11. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
[TBL] [Abstract][Full Text] [Related]
12. [Impact of the heterogenicity of amino acid sequence on the immunoreactivity of an antigenic epitopic complex localized within amino acids 1192-1456 of protein NS3 protein of hepatitis C virus].
Ulanova TI; Puzyrev VF; Burkov AN; Obriadina AP
Vopr Virusol; 2006; 51(1):28-30. PubMed ID: 16515039
[TBL] [Abstract][Full Text] [Related]
13. Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
Zhang ZX; Chen M; Sönnerborg A; Sällberg M
Clin Diagn Lab Immunol; 1994 May; 1(3):290-4. PubMed ID: 7496964
[TBL] [Abstract][Full Text] [Related]
14. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
15. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
[TBL] [Abstract][Full Text] [Related]
16. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
[TBL] [Abstract][Full Text] [Related]
17. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
Simmonds P; Rose KA; Graham S; Chan SW; McOmish F; Dow BC; Follett EA; Yap PL; Marsden H
J Clin Microbiol; 1993 Jun; 31(6):1493-503. PubMed ID: 7686182
[TBL] [Abstract][Full Text] [Related]
18. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.
Khudyakov Yu E; Khudyakova NS; Jue DL; Lambert SB; Fang S; Fields HA
Virology; 1995 Jan; 206(1):666-72. PubMed ID: 7530398
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
[TBL] [Abstract][Full Text] [Related]
20. Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses.
Muñoz de Rueda P; Casado J; Patón R; Quintero D; Palacios A; Gila A; Quiles R; León J; Ruiz-Extremera A; Salmerón J
J Virol; 2008 Jul; 82(13):6644-53. PubMed ID: 18448540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
